United Therapeutics Corporation logo

Senior/Advanced Lung Disease Sales Specialist (Richmond, VA) *Rare Disease Opportunity*

United Therapeutics Corporation
4 months ago
Remote friendly (Virginia, United States)
United States
$130,000 - $180,000 USD yearly
Sales
Responsibilities:
- Promote Tyvaso (and other UT products) in a defined territory and designated accounts; interface with the PH-ILD/IPF community.
- Build and maintain relationships with HCPs and customer types (MDs, NPs, PAs, RNs, specialty distributors) to provide product messaging and education.
- Analyze sales reports; create and execute business plans to grow sales and achieve/exceed targets.
- Coordinate with other field team members; use available resources to drive sales.
- Maintain expert knowledge of disease state, product, and competitive landscape.
- Use sales force automation; complete administrative requirements (e.g., expense and call reporting).
- Attend medical symposia/conferences; support and attend patient support group meetings.
- Travel and attend UT offices and national events as needed for customer interaction.

Qualifications (ALD Specialist – Minimum):
- Bachelor’s degree (preferably nursing/life science) or equivalent.
- 6+ years selling specialty pharmaceutical therapies OR 6+ years advanced lung disease healthcare/nursing.
- 2+ years Cardiovascular and/or Pulmonary therapeutics; therapeutic area expertise.
- Strong leadership, communication, decision-making, planning, interpersonal skills; UT product/service knowledge.
- Valid driver’s license.

Preferred (ALD Specialist):
- 2+ years specialty pharma/biotech sales; 2+ years PH-ILD and/or IPF sales; 2+ years institutional/major teaching centers.

Benefits (as stated): medical/dental/vision/prescription, wellness resources, 401(k) & ESPP, paid time off & paid parental leave, disability, and more.

Senior ALD Specialist (Minimum additions): 8+ years sales; 4+ years specialty pharma/biotech; 4+ years institutional/teaching centers; 1+ year training workshop facilitation (required).